Elevated LCN2 expression in IPF lung tissues and bronchoalveolar lavage fluid (BALF) correlates with reduced respiratory function (61), positioning it as a surrogate biomarker of disease severity. The gene discussed is LCN2; the disease is idiopathic pulmonary fibrosis.